Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Adult stem cells are important for tissue repair and have therapeutic potential, but more research is needed to fully use them.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Erlotinib can cause hair loss as a side effect.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The WNT signaling pathway is crucial for mesenchymal stem cells' function and therapy success.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Cured meats in Nigeria have high cadmium levels, posing health risks.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

We need better ways to test and understand SARMs to make safer and more effective treatments.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.